Table 2.
Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)
Days | Subjects at risk | Lost to follow up | Therapeutic failure | IR | CITF |
---|---|---|---|---|---|
0 | 125 | 0 | 0 | 1.00 | 0 |
2 | 125 | 0 | 0 | 1.00 | 0 |
3 | 125 | 0 | 1 | 0.99 | 0.01 |
7 | 124 | 3 | 0 | 0.99 | 0.01 |
14 | 121 | 0 | 0 | 0.99 | 0.01 |
21 | 121 | 0 | 0 | 0.99 | 0.01 |
28 | 121 | 0 | 0 | 0.99 | 0.01 |
IR interval risk, CITF cumulative incidence of therapeutic failure.